Prostate Cancer Update

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Prostate Cancer Nov 20, 2024

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer.

Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder Cancer Aug 30, 2024

Dr Michiel van der Heijden from the Netherlands Cancer Institute in Amsterdam discusses the management of metastatic urothelial bladder cancer.

Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer Aug 02, 2024

Dr Matthew R Smith from the Massachusetts General Hospital Cancer Center in Boston summarizes recent developments presented at ASCO 2024 for prostate cancer.

Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review Jul 18, 2024

Dr Rana R McKay from Moores Cancer Center in La Jolla, California, and Prof Thomas Powles from Barts Cancer Institute in London, United Kingdom, discuss recent updates on available and novel treatment strategies for renal cell carcinoma.

Oncology Today with Dr Neil Love: Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer Jun 18, 2024

Dr Petros Grivas from the Fred Hutchinson Cancer Center in Seattle, Washington, discusses the current management of advanced urothelial bladder cancer.

Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer Jun 07, 2024

Dr Matthew Galsky from The Tisch Cancer Institute in New York and Dr Ashish Kamat from The University of Texas MD Anderson Cancer Center in Houston summarize recent clinical advances in the management of urothelial bladder cancer, including data from the 2024 AUA annual meeting.

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition May 07, 2024

Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field.

Oncology Today with Dr Neil Love: Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium Apr 25, 2024

Dr Emmanuel Antonarakis from the University of Minnesota in Minneapolis reviews research findings presented at the 2024 Genitourinary Cancers Symposium and provides his perspectives on current and novel treatment approaches for prostate cancer.

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer Apr 05, 2024

Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer.

Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates Apr 04, 2024

Dr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors.

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer Mar 28, 2024

Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer.

Virtual Case Library: Metastatic Urothelial Bladder Cancer Mar 13, 2024

Drs Petros Grivas, Vadim S Koshkin, Kriti Mittal, Mamta Parikh and Scott T Tagawa discuss available and emerging research, patient cases from participating junior clinical investigators and the perspectives of senior clinical investigator faculty on data informing their decision-making for patients with metastatic urothelial bladder cancer.

Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer Sep 01, 2023

Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer.

Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Aug 25, 2023

Dr Rana McKay from UC San Diego Moores Cancer Center in La Jolla, California discusses key presentations on genitourinary cancers from the 2023 ASCO Annual Meeting.

Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer Aug 14, 2023

Featuring a roundtable discussion on the current and future role of PARP inhibitor-based therapy in the management of prostate cancer, with Drs Neeraj Agarwal, Emmanuel Antonarakis, Susan Slovin, and Prof Karim Fizazi, moderated by Dr Neil Love.

Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer Aug 10, 2023

Dr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Professor Petros Grivas from the Fred Hutchinson Cancer Research Center in Seattle, Washington, discuss available and novel treatment strategies for metastatic urothelial bladder cancer, moderated by Dr Neil Love.

Management of Urothelial Bladder Cancer with Dr Matthew Galsky Jul 24, 2023

Dr Matthew Galsky from The Tisch Cancer Institute in New York, New York, discusses recent updates from ASCO 2023 on the management of urothelial bladder cancer, moderated by Dr Neil Love.

Oncology Today with Dr Neil Love: Special Edition — What I Tell My Patients About New Treatments and Clinical Trials in Urothelial Bladder Cancer Jul 20, 2023

Featuring a discussion on the presentation and management of urothelial bladder cancer with Dr Elizabeth Plimack, moderated by Dr Neil Love.

Investigator Perspectives on Available Research Findings and Challenging Questions in Renal Cell Carcinoma Jul 17, 2023

Featuring perspectives from Dr David F McDermott and Dr Sumanta Kumar Pal, moderated by Dr Neil Love.

What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Urothelial Bladder Cancer Jun 23, 2023

Proceedings from a webinar held in partnership with the 2023 ONS Congress. Featuring a discussion on the management of urothelial bladder cancer with Ms Brenda Martone and Dr Jonathan E Rosenberg, moderated by Dr Neil Love.

Oncology Today: Recent Research Advances in Prostate Cancer and the Clinical Implications – A 2023 Post-ASCO GU Activity May 05, 2023

Featuring perspectives from Drs Andrew J Armstrong and Rana R McKay, moderated by Dr Neil Love.

Oncology Today with Dr Neil Love: Special Edition — Recent Research Advances in Prostate Cancer and the Clinical Implications (Faculty Interview) May 05, 2023

Featuring perspectives from Dr Daniel Petrylak, moderated by Dr Neil Love.

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Renal Cell Carcinoma and Bladder Cancer Apr 18, 2023

Proceedings from our Year in Review webinar on the management of renal cell carcinoma and bladder cancer. Featuring perspectives from Dr Matthew Milowsky and Prof Thomas Powles, moderated by Dr Neil Love.

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer Apr 06, 2023

Proceedings from our Year in Review webinar on the management of prostate cancer. Featuring perspectives from Drs Tanya Dorff and A Oliver Sartor, moderated by Dr Neil Love.

Recent Advances and Future Directions in Genitourinary Cancers — With Dr Daniel Petrylak and Dr Sandy Srinivas (Proceedings from a Symposium in Partnership with NCOA and SCOS) Mar 17, 2023

Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.

Oncology Today with Dr Neil Love: Managing Metastatic Urothelial Bladder Cancer Jan 05, 2023

Featuring a discussion on current treatments for metastatic urothelial bladder cancer with Dr Scott Tagawa, moderated by Dr Neil Love.

Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 2 of a 2-Part Series Dec 07, 2022

Featuring a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Prof Karim Fizazi and Prof Stéphane Oudard, moderated by Dr Neil Love.

Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma Nov 29, 2022

Featuring a discussion on recent advances in the treatment of renal cell carcinoma with Dr Toni Choueiri, moderated by Dr Neil Love.

The Clinical Implications of Key Recent Data Sets in Prostate and Bladder Cancers — With Drs Alicia Morgans and Evan Yu (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists) Nov 16, 2022

Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in prostate and bladder cancers. Featuring perspectives from Drs Alicia Morgans and Evan Yu, moderated by Dr Neil Love.

The Clinical Implications of Key Recent Data Sets in Renal Cell Carcinoma — With Prof Thomas Powles (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists) Nov 16, 2022

Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in renal cell carcinoma. Featuring perspectives from Prof Thomas Powles, moderated by Dr Neil Love.

Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 1 of a 2-Part Series Nov 09, 2022

Featuring a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Dr Matthew Smith, moderated by Dr Neil Love.

Oncology Today with Dr Neil Love: Neuroendocrine Tumors Nov 01, 2022

Featuring a discussion on recent advances in understanding and treating neuroendocrine tumors with Dr Pamela Kunz, moderated by Dr Neil Love.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected